Lilly confirms date and conference call for third-quarter 2024 financial results announcement
Eli Lilly and Company (NYSE: LLY) has announced that it will release its third-quarter 2024 financial results on October 30, 2024. The company will also host a conference call at 10 a.m. Eastern time on the same day to discuss the financial performance with investors, media, and the general public.
A live webcast of the conference call will be accessible through a link on Lilly's investor relations website. For those unable to attend the live event, a replay will be available on the same website following the conference call.
Eli Lilly and Company (NYSE: LLY) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 30 ottobre 2024. L'azienda ospiterà anche una conferenza telefonica alle 10 del mattino, ora orientale, lo stesso giorno per discutere le performance finanziarie con investitori, media e il pubblico generale.
Un webcast dal vivo della conferenza telefonica sarà accessibile tramite un link sul sito web delle relazioni con gli investitori di Lilly. Per coloro che non possono partecipare all'evento dal vivo, una registrazione sarà disponibile sullo stesso sito dopo la conferenza telefonica.
Eli Lilly and Company (NYSE: LLY) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el 30 de octubre de 2024. La compañía también llevará a cabo una llamada de conferencia a las 10 a.m., hora del este el mismo día para discutir el desempeño financiero con inversores, medios de comunicación y el público en general.
Una transmisión en vivo de la llamada de conferencia estará disponible a través de un enlace en el sitio web de relaciones con inversores de Lilly. Para aquellos que no puedan asistir al evento en vivo, una repetición estará disponible en el mismo sitio web después de la llamada de conferencia.
엘리 릴리 앤 컴퍼니 (NYSE: LLY)는 2024년 3분기 재무 결과를 2024년 10월 30일에 발표할 예정이라고 발표했습니다. 회사는 같은 날 오전 10시 동부 표준시 컨퍼런스 콜을 개최하여 투자자, 미디어 및 일반 대중과 함께 재무 성과를 논의할 것입니다.
컨퍼런스 콜의 실시간 웹캐스트는 릴리의 투자자 관계 웹사이트의 링크를 통해 접근할 수 있습니다. 실시간 이벤트에 참석할 수 없는 분들을 위해, 다시 보기가 제공될 것이며, 이는 컨퍼런스 콜 후 같은 웹사이트에서 확인할 수 있습니다.
Eli Lilly and Company (NYSE: LLY) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le 30 octobre 2024. L'entreprise organisera également une conférence téléphonique à 10 heures, heure de l'Est le même jour pour discuter de ses performances financières avec des investisseurs, des médias et le grand public.
Un webcast en direct de la conférence téléphonique sera accessible via un lien sur le site Web des relations avec les investisseurs de Lilly. Pour ceux qui ne peuvent pas assister à l'événement en direct, un rediffusion sera disponible sur le même site après la conférence téléphonique.
Eli Lilly and Company (NYSE: LLY) hat bekannt gegeben, dass es seine Finanzergebnisse für das dritte Quartal 2024 am 30. Oktober 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 10 Uhr Eastern Time eine Telefonkonferenz abhalten, um die finanzielle Leistung mit Investoren, Medien und der Öffentlichkeit zu erörtern.
Ein Live-Webcast der Telefonkonferenz wird über einen Link auf der Investor-Relations-Website von Lilly zugänglich sein. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine Aufzeichnung verfügbar sein, die nach der Telefonkonferenz auf derselben Website abrufbar ist.
- None.
- None.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-374-1878 (Media) |
Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2024-financial-results-announcement-302276899.html
SOURCE Eli Lilly and Company
FAQ
When will Eli Lilly (LLY) release its Q3 2024 financial results?
What time is Eli Lilly's (LLY) Q3 2024 earnings conference call?
How can investors access Eli Lilly's (LLY) Q3 2024 earnings call?
Will there be a replay available for Eli Lilly's (LLY) Q3 2024 earnings call?
